Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hong

Showing results (1181-1190 of 1,404) with videos related to

Pageof 141
Sort By:
The Journal of Invasive Cardiology|January 6, 2010
Increased vascular access complications in patients with renal dysfunction undergoing percutaneous coronary procedures using arteriotomy closure devicesEmad F Aziz, Sandeep Pulimi, Clinton Coleman, et al.
Cancer|April 3, 2001
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinomaD M Shin, F R Khuri, B S Glisson, et al.
Cancer Research|December 1, 1995
Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptorsY H Kim, D F Dohi, G R Han, et al.
Journal of the American College of Surgeons|April 18, 2017
Why Do Long-Distance Travelers Have Improved Pancreatectomy Outcomes?Manila Jindal, Chaoyi Zheng, Humair S Quadri, et al.
Human Gene Therapy|March 27, 2001
Cochlear gene delivery through an intact round window membrane in mouseJ Jero, A N Mhatre, C J Tseng, et al.
Zhonghua Yi Xue Za Zhi|April 26, 2018
[Relationship between FGF23/FGFR4 expression in atrial tissue and atrial fibrosis in patients with atrial fibrillation]Q B Dong, Y H Tang, W X Wang, et al.
Cancer|February 12, 2009
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancerEdward S Kim, Ann M Mauer, William N William, et al.
American Journal of Clinical Oncology|April 1, 1990
Ifosfamide with mesna uroprotection in the management of lung cancerP Y Holoye, B S Glisson, J S Lee, et al.
Nuclear Medicine and Biology|July 1, 1997
In vitro and in vivo properties of murine monoclonal antibody for a novel immature thymocyte-differentiated antigen, JL1J K Chung, Y So, M K Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancerAmir Onn, Arlene M Correa, Michael Gilcrease, et al.
Pageof 141

Showing results (1181-1190 of 1,404) with videos related to

Sort By:
Pageof 141
The Journal of Invasive Cardiology|January 6, 2010
Increased vascular access complications in patients with renal dysfunction undergoing percutaneous coronary procedures using arteriotomy closure devicesEmad F Aziz, Sandeep Pulimi, Clinton Coleman, et al.
Cancer|April 3, 2001
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinomaD M Shin, F R Khuri, B S Glisson, et al.
Cancer Research|December 1, 1995
Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptorsY H Kim, D F Dohi, G R Han, et al.
Journal of the American College of Surgeons|April 18, 2017
Why Do Long-Distance Travelers Have Improved Pancreatectomy Outcomes?Manila Jindal, Chaoyi Zheng, Humair S Quadri, et al.
Human Gene Therapy|March 27, 2001
Cochlear gene delivery through an intact round window membrane in mouseJ Jero, A N Mhatre, C J Tseng, et al.
Zhonghua Yi Xue Za Zhi|April 26, 2018
[Relationship between FGF23/FGFR4 expression in atrial tissue and atrial fibrosis in patients with atrial fibrillation]Q B Dong, Y H Tang, W X Wang, et al.
Cancer|February 12, 2009
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancerEdward S Kim, Ann M Mauer, William N William, et al.
American Journal of Clinical Oncology|April 1, 1990
Ifosfamide with mesna uroprotection in the management of lung cancerP Y Holoye, B S Glisson, J S Lee, et al.
Nuclear Medicine and Biology|July 1, 1997
In vitro and in vivo properties of murine monoclonal antibody for a novel immature thymocyte-differentiated antigen, JL1J K Chung, Y So, M K Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancerAmir Onn, Arlene M Correa, Michael Gilcrease, et al.
Pageof 141